Regeneron files reply for injunction against Amgen in US cholesterol drug antitrust case
MLex Summary: Regeneron filed a reply in support of its request for a permanent injunction against Amgen regarding cholesterol-reducing medication, saying Amgen ignores the fact that a jury already found its...To view the full article, register now.
Already a subscriber? Click here to view full article